Elite Test Bank: Ham’s
Primary Care Geriatrics (7th
Ed.) & 2026/2027 Clinical
Standards
PART 0: THE NAVIGATOR
● Part I: The Primer
○ The "Welcome to the Big Leagues" Hook
○ The 2026/2027 Critical Action Cheat Sheet
● Part II: The Elite Test Bank
○ Questions 1–28: Foundational Syntax & Application (The Hard Deck)
○ Questions 29–58: Professional Simulation (Immediate Action Drills)
○ Questions 59–88: Grandmaster Synthesis (Crisis & Complexity)
PART I: THE PRIMER
Using this test bank will intercept fatal professional errors before they reach a patient. You are
moving beyond academic memorization; this gauntlet builds the clinical intuition required to
navigate high-stakes, multi-morbid geriatric care using updated 2026/2027 standards.
The 2026/2027 Critical Action Cheat Sheet
Clinical Domain 2026/2027 Standard / Guideline Critical Application Directive
Assessment The Geriatric 5Ms Every decision must filter
through Mind, Mobility,
Medications, Multicomplexity,
and Matters Most.
Pharmacology 2026 AGS Beers Criteria Less is more. Use
non-pharmacologic alternatives
FIRST. Apixaban is the DOAC
of choice over
rivaroxaban/warfarin. Never
use Z-drugs (zolpidem) or
antipsychotics for
delirium/insomnia without
exhausting behavioral therapy.
,Clinical Domain 2026/2027 Standard / Guideline Critical Application Directive
Cardiology 2025/2026 AHA/ACC HTN The universal target for adults,
Guidelines including geriatrics (to prevent
cognitive decline), is <130/80
mm Hg, calculated via the
race-independent PREVENT
equation.
Endocrinology 2026 ADA Standards Minimum protein intake is 0.8
g/kg/day to prevent
sarcopenia. Use SGLT2
inhibitors and GLP-1 agonists
early for multi-morbid older
adults to prevent renal/cardiac
collapse.
Neurology Anti-Amyloid Therapeutics Lecanemab/Donanemab
require early disease staging
(MCI/mild) and strict MRI
monitoring for Amyloid-Related
Imaging Abnormalities (ARIA).
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: Under the 2025/2026 AHA/ACC High Blood Pressure Guidelines, which tool is NOW
REQUIRED to calculate 10-year cardiovascular risk, omitting race as a variable to improve
generalizability? A) The Pooled Cohort Equation (PCE) B) The Framingham Risk Score C) The
PREVENT Equation D) The CHA2DS2-VASc Score
● The Answer: C (The PREVENT Equation)
● Distractor Analysis: A is incorrect: The PCE is a legacy tool replaced due to risk
underestimation in diverse populations. B is incorrect: Framingham is outdated for this
specific guideline update. D is incorrect: This calculates stroke risk in atrial fibrillation, not
baseline ASCVD risk.
The Mentor's Analysis: The shift to the PREVENT equation removes biological essentialism
(race) from algorithms, substituting it with precise measures of cardiovascular-kidney-metabolic
health and social determinants. Professional Intuition: Treat the physiology and the
socioeconomic reality, not the demographic checkbox.
Q2: A 78-year-old client with type 2 diabetes and frailty is assessed for nutritional adequacy per
2026 ADA standards. To prevent further lean muscle mass loss (sarcopenia), the practitioner
must ensure a minimum daily protein intake of: A) 0.5 g/kg B) 0.8 g/kg C) 1.5 g/kg D) 2.0 g/kg
● The Answer: B (0.8 g/kg)
● Distractor Analysis: A is incorrect: This will rapidly accelerate muscle wasting. C & D are
incorrect: These are high-target athletic ranges that may overload declining renal
clearance in a standard geriatric patient.
The Mentor's Analysis: Sarcopenia is a silent killer in diabetic older adults. Prescribing a diet
without protein parameters is clinical negligence. Professional Intuition: Muscle is the armor of
the elderly. You must actively prescribe protein just as you prescribe insulin.
Q3: The 2026 AGS Beers Criteria update explicitly warns against combining gabapentinoids
, with which class of medications due to severe risks of profound sedation and respiratory
depression? A) SSRIs B) Proton Pump Inhibitors C) Benzodiazepines D) SGLT2 Inhibitors
● The Answer: C (Benzodiazepines)
● Distractor Analysis: A, B, & D are incorrect: While polypharmacy is always a concern,
the specific lethal CNS depression warning in the 2026 update targets the stacking of
gabapentin with benzodiazepines or opioids.
The Mentor's Analysis: Both gabapentinoids and benzodiazepines suppress neural firing.
Stacking them in a geriatric patient with age-reduced respiratory reserve is a pharmacological
ambush. Professional Intuition: Never stack sedatives. The brain will forget to tell the lungs to
breathe.
Q4: A client is newly diagnosed with mild cognitive impairment (MCI) due to Alzheimer's
disease. The family asks about initiating donanemab (Kisunla). Which diagnostic confirmation is
ABSOLUTELY REQUIRED before initiation? A) A Mini-Mental State Examination (MMSE)
score below 15. B) Confirmation of amyloid pathology via PET scan or cerebrospinal fluid
analysis. C) A genetic test positive for the APOE ε4 allele. D) A failed trial of donepezil.
● The Answer: B (Confirmation of amyloid pathology via PET scan or cerebrospinal fluid
analysis.)
● Distractor Analysis: A is incorrect: An MMSE below 15 indicates moderate-to-severe
disease, contraindicating these drugs. C is incorrect: APOE genotyping stratifies ARIA
risk but is not the primary diagnostic gateway. D is incorrect: Step therapy is not a
prerequisite.
The Mentor's Analysis: Anti-amyloid therapies are precision weapons. You cannot clear
amyloid if you haven't proven it is there. Professional Intuition: Never deploy high-risk,
high-cost biologics based on clinical suspicion alone. Prove the target exists.
Q5: An 85-year-old client presents with acute delirium. The nursing home staff requests a
prescription for haloperidol to manage agitation. Based on the 2026 AGS Beers Criteria, what is
the INITIAL action? A) Prescribe haloperidol but monitor for QT prolongation. B) Substitute
haloperidol with quetiapine for a safer profile. C) Deny the prescription and initiate non-drug
behavioral strategies and a medical workup. D) Administer diphenhydramine to sedate the client
safely.
● The Answer: C (Deny the prescription and initiate non-drug behavioral strategies and a
medical workup.)
● Distractor Analysis: A & B are incorrect: All antipsychotics increase the risk of stroke
and cognitive decline and are strictly cautioned against for general agitation. D is
incorrect: Diphenhydramine causes severe anticholinergic toxicity and exacerbates
delirium.
The Mentor's Analysis: Delirium is a medical emergency, not a psychiatric annoyance.
Antipsychotics mask the symptom while the underlying infection kills the patient. Professional
Intuition: Behavioral agitation in a geriatric patient is a vital sign indicating physiological
distress. Find the cause; do not chemically restrain the alarm.
Q6: Which framework should a primary care practitioner utilize to systematically evaluate a
geriatric patient with multiple chronic conditions, ensuring patient preferences are centralized?
A) The PQRST Assessment B) The Geriatric 5Ms C) The Beer's Inventory D) The SPICES Tool
● The Answer: B (The Geriatric 5Ms)
● Distractor Analysis: A is incorrect: PQRST is for acute pain assessment. C is incorrect:
Beers is for medication safety. D is incorrect: SPICES is a nursing screening tool, lacking
the "Matters Most" shared-decision focus of the 5Ms.
The Mentor's Analysis: The 5Ms (Mind, Mobility, Medications, Multicomplexity, Matters Most)
Primary Care Geriatrics (7th
Ed.) & 2026/2027 Clinical
Standards
PART 0: THE NAVIGATOR
● Part I: The Primer
○ The "Welcome to the Big Leagues" Hook
○ The 2026/2027 Critical Action Cheat Sheet
● Part II: The Elite Test Bank
○ Questions 1–28: Foundational Syntax & Application (The Hard Deck)
○ Questions 29–58: Professional Simulation (Immediate Action Drills)
○ Questions 59–88: Grandmaster Synthesis (Crisis & Complexity)
PART I: THE PRIMER
Using this test bank will intercept fatal professional errors before they reach a patient. You are
moving beyond academic memorization; this gauntlet builds the clinical intuition required to
navigate high-stakes, multi-morbid geriatric care using updated 2026/2027 standards.
The 2026/2027 Critical Action Cheat Sheet
Clinical Domain 2026/2027 Standard / Guideline Critical Application Directive
Assessment The Geriatric 5Ms Every decision must filter
through Mind, Mobility,
Medications, Multicomplexity,
and Matters Most.
Pharmacology 2026 AGS Beers Criteria Less is more. Use
non-pharmacologic alternatives
FIRST. Apixaban is the DOAC
of choice over
rivaroxaban/warfarin. Never
use Z-drugs (zolpidem) or
antipsychotics for
delirium/insomnia without
exhausting behavioral therapy.
,Clinical Domain 2026/2027 Standard / Guideline Critical Application Directive
Cardiology 2025/2026 AHA/ACC HTN The universal target for adults,
Guidelines including geriatrics (to prevent
cognitive decline), is <130/80
mm Hg, calculated via the
race-independent PREVENT
equation.
Endocrinology 2026 ADA Standards Minimum protein intake is 0.8
g/kg/day to prevent
sarcopenia. Use SGLT2
inhibitors and GLP-1 agonists
early for multi-morbid older
adults to prevent renal/cardiac
collapse.
Neurology Anti-Amyloid Therapeutics Lecanemab/Donanemab
require early disease staging
(MCI/mild) and strict MRI
monitoring for Amyloid-Related
Imaging Abnormalities (ARIA).
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: Under the 2025/2026 AHA/ACC High Blood Pressure Guidelines, which tool is NOW
REQUIRED to calculate 10-year cardiovascular risk, omitting race as a variable to improve
generalizability? A) The Pooled Cohort Equation (PCE) B) The Framingham Risk Score C) The
PREVENT Equation D) The CHA2DS2-VASc Score
● The Answer: C (The PREVENT Equation)
● Distractor Analysis: A is incorrect: The PCE is a legacy tool replaced due to risk
underestimation in diverse populations. B is incorrect: Framingham is outdated for this
specific guideline update. D is incorrect: This calculates stroke risk in atrial fibrillation, not
baseline ASCVD risk.
The Mentor's Analysis: The shift to the PREVENT equation removes biological essentialism
(race) from algorithms, substituting it with precise measures of cardiovascular-kidney-metabolic
health and social determinants. Professional Intuition: Treat the physiology and the
socioeconomic reality, not the demographic checkbox.
Q2: A 78-year-old client with type 2 diabetes and frailty is assessed for nutritional adequacy per
2026 ADA standards. To prevent further lean muscle mass loss (sarcopenia), the practitioner
must ensure a minimum daily protein intake of: A) 0.5 g/kg B) 0.8 g/kg C) 1.5 g/kg D) 2.0 g/kg
● The Answer: B (0.8 g/kg)
● Distractor Analysis: A is incorrect: This will rapidly accelerate muscle wasting. C & D are
incorrect: These are high-target athletic ranges that may overload declining renal
clearance in a standard geriatric patient.
The Mentor's Analysis: Sarcopenia is a silent killer in diabetic older adults. Prescribing a diet
without protein parameters is clinical negligence. Professional Intuition: Muscle is the armor of
the elderly. You must actively prescribe protein just as you prescribe insulin.
Q3: The 2026 AGS Beers Criteria update explicitly warns against combining gabapentinoids
, with which class of medications due to severe risks of profound sedation and respiratory
depression? A) SSRIs B) Proton Pump Inhibitors C) Benzodiazepines D) SGLT2 Inhibitors
● The Answer: C (Benzodiazepines)
● Distractor Analysis: A, B, & D are incorrect: While polypharmacy is always a concern,
the specific lethal CNS depression warning in the 2026 update targets the stacking of
gabapentin with benzodiazepines or opioids.
The Mentor's Analysis: Both gabapentinoids and benzodiazepines suppress neural firing.
Stacking them in a geriatric patient with age-reduced respiratory reserve is a pharmacological
ambush. Professional Intuition: Never stack sedatives. The brain will forget to tell the lungs to
breathe.
Q4: A client is newly diagnosed with mild cognitive impairment (MCI) due to Alzheimer's
disease. The family asks about initiating donanemab (Kisunla). Which diagnostic confirmation is
ABSOLUTELY REQUIRED before initiation? A) A Mini-Mental State Examination (MMSE)
score below 15. B) Confirmation of amyloid pathology via PET scan or cerebrospinal fluid
analysis. C) A genetic test positive for the APOE ε4 allele. D) A failed trial of donepezil.
● The Answer: B (Confirmation of amyloid pathology via PET scan or cerebrospinal fluid
analysis.)
● Distractor Analysis: A is incorrect: An MMSE below 15 indicates moderate-to-severe
disease, contraindicating these drugs. C is incorrect: APOE genotyping stratifies ARIA
risk but is not the primary diagnostic gateway. D is incorrect: Step therapy is not a
prerequisite.
The Mentor's Analysis: Anti-amyloid therapies are precision weapons. You cannot clear
amyloid if you haven't proven it is there. Professional Intuition: Never deploy high-risk,
high-cost biologics based on clinical suspicion alone. Prove the target exists.
Q5: An 85-year-old client presents with acute delirium. The nursing home staff requests a
prescription for haloperidol to manage agitation. Based on the 2026 AGS Beers Criteria, what is
the INITIAL action? A) Prescribe haloperidol but monitor for QT prolongation. B) Substitute
haloperidol with quetiapine for a safer profile. C) Deny the prescription and initiate non-drug
behavioral strategies and a medical workup. D) Administer diphenhydramine to sedate the client
safely.
● The Answer: C (Deny the prescription and initiate non-drug behavioral strategies and a
medical workup.)
● Distractor Analysis: A & B are incorrect: All antipsychotics increase the risk of stroke
and cognitive decline and are strictly cautioned against for general agitation. D is
incorrect: Diphenhydramine causes severe anticholinergic toxicity and exacerbates
delirium.
The Mentor's Analysis: Delirium is a medical emergency, not a psychiatric annoyance.
Antipsychotics mask the symptom while the underlying infection kills the patient. Professional
Intuition: Behavioral agitation in a geriatric patient is a vital sign indicating physiological
distress. Find the cause; do not chemically restrain the alarm.
Q6: Which framework should a primary care practitioner utilize to systematically evaluate a
geriatric patient with multiple chronic conditions, ensuring patient preferences are centralized?
A) The PQRST Assessment B) The Geriatric 5Ms C) The Beer's Inventory D) The SPICES Tool
● The Answer: B (The Geriatric 5Ms)
● Distractor Analysis: A is incorrect: PQRST is for acute pain assessment. C is incorrect:
Beers is for medication safety. D is incorrect: SPICES is a nursing screening tool, lacking
the "Matters Most" shared-decision focus of the 5Ms.
The Mentor's Analysis: The 5Ms (Mind, Mobility, Medications, Multicomplexity, Matters Most)
